Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 Read more about Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Master Rollover Protocol for Continued Safety Assessment of Study Drug Read more about Master Rollover Protocol for Continued Safety Assessment of Study Drug
CTL019 Out of Specification MAP for ALL or DLBCL Patients Read more about CTL019 Out of Specification MAP for ALL or DLBCL Patients
Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia Read more about Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia
Individual Patient Compassionate Use of Fedratinib Read more about Individual Patient Compassionate Use of Fedratinib
Intermediate Expanded Access Protocol CNMAu8.EAP03 Read more about Intermediate Expanded Access Protocol CNMAu8.EAP03
Expanded Access to Ensartinib for Participants With ALK+ NSCLC Read more about Expanded Access to Ensartinib for Participants With ALK+ NSCLC
Early Access Program With Arimoclomol in US Patients With NPC Read more about Early Access Program With Arimoclomol in US Patients With NPC
Expanded Access for ATB200/AT2221 for the Treatment of IOPD Read more about Expanded Access for ATB200/AT2221 for the Treatment of IOPD
